Guest Posting

If you wish to write and/or publish an article on Operation Disclosure all you need to do is send your entry to UniversalOm432Hz@gmail.com applying these following rules.


The subject of your email entry should be: "Entry Post | (Title of your post) | Operation Disclosure"

- Must be in text format
- Proper Grammar
- No foul language
- Your signature/name/username at the top

Send your entry and speak out today!

News Alerts

RV/INTELLIGENCE ALERT - October 21, 2017


SOMETHING MAJOR HAS CHANGED FROM PREVIOUS REPORTS.


TRUMP WAS ELECTED BY THE APTB/NPTB FOR A SPECIFIC REASON.


TO DRAW THE CABAL OUT IN THE U.S. AND WORLDWIDE.


THIS IS WHY THERE IS SO MUCH CHAOS AND HATE TOWARDS TRUMP.


TRUMP WAS CHOSEN TO BRING OUT ALL OF THE ISSUES IN THE U.S., TAKING IN ALL OF THE CRITICISM, AND BRINGING FORTH CHANGE (GESARA).


MEANWHILE THE RESTORED REPUBLIC CONTINUES TO REFORM THE COUNTRY BEHIND THE SCENES.


TRUMP WILL BE DISCLOSING VARIOUS TOPICS SUCH AS JFK, 9/11, SECRET SPACE PROGRAMS AND MORE.


THESE DISCLOSURE EVENTS ARE PART OF THE CHAIN OF EVENTS LEADING UP TO THE GCR/RV.


TRUMP WILL EXPOSE THE CABAL MORE AND MORE UNTIL THERE IS ENOUGH FOR THE MASS ARRESTS TO BEGIN.


"DRAIN THE SWAMP" AS HE SAID. HE WAS ALREADY DISCLOSING "THE PLAN" FROM THE VERY BEGINNING.


NOW FOR THE WEIRD PART.


THERE ARE TWO CLONES OF TRUMP BEING USED BY THE APTB/NPTB. ONE CLONE WEARS A RED TIE, THE OTHER A BLUE TIE.


HUMAN TRUMP IS NOT WHO YOU THINK HE IS AND IS RARELY SEEN IN PUBLIC BUT HE IS IN-FACT INTERIM PRESIDENT OF THE RESTORED REPUBLIC. HE HAS BEEN WORKING WITH THE RESTORED REPUBLIC BEHIND THE SCENES THIS WHOLE TIME. THE TRUMP CLONES ARE THE ONES ACTING AS PRESIDENT OF THE CURRENT USA, INC. THEY ARE THE ONES YOU SEE ON TV. HUMAN TRUMP ONLY RARELY APPEARS ON TV TO SIGN EXECUTIVE ORDERS.


ONCE THE MASS ARRESTS BEGIN AFTER SEVERAL DISCLOSURES, THE USA, INC. WILL BE DISSOLVED, ALL CLONES WILL BE DEACTIVATED, AND HUMAN TRUMP WILL STEP IN AS PRESIDENT OF THE REPUBLIC.


THIS WAS ALL AGREED UPON FOR A SMOOTH TRANSITION. THE PUBLIC WILL NEVER KNOW ABOUT THE SEVERAL TRUMPS, THE SUDDEN RESTORATION OF THE REPUBLIC, AND THE FULL IMPLEMENTATION OF GESARA. IT WILL APPEAR AS TRUMP WAS PRESIDENT THIS WHOLE TIME. THIS WILL NOT BE DISCLOSED TO THE PUBLIC UNTIL MUCH LATER IN THE FUTURE.


WATCH THE NEWS FOR DISCLOSURES.


JFK DISCLOSURE IS UP NEXT AND THERE WILL BE MORE AFTER.


WITH EACH DISCLOSURE, WE GET CLOSER TO THE MASS ARRESTS.


THE MASS ARRESTS IS THE TRIGGER FOR THE GCR/RV TO BEGIN.


---


FOR MORE INFORMATION ABOUT THE RV/GCR VISIT:


http://www.dinarchronicles.com/intel.html


---

Featured Post

Restored Republic via a GCR as of Oct. 22, 2017

Restored Republic via a GCR Update as of Oct. 22 2017 Compiled 12:05 am EDT 22 Oct. 2017 by Judy Byington, MSW, LCSW, ret, CEO, Child Abus...

Saturday, January 14, 2017

Trump Wipes $24.6 Bln Off Drug and Biotech Stocks in 20 Minutes

Source: The Event Chronicle | by Kristian Rouz

US big pharma suffered a major hit during Wednesday's press conference of the President-elect Donald Trump, who blasted drugmakers for making their product overseas and subsequently importing it, and vowed to introduce proper bidding procedures in order to curb drug prices and "save billions."

Biotech and drugmaker stocks slumped in the immediate aftermath of these remarks, reflecting the market perception of the big pharma as artificially overpriced. Pharmaceutical and biotech equities crashed on Wednesday after President-elect Donald Trump blasted the "big pharma" lobbying practices as artificially driving prices and supporting vicious foreign trade patterns.

"They're getting away with murder," Trump said. "Pharma has a lot of lobbyists and a lot of power and there is very little bidding. We're the largest buyer of drugs in the world and yet we don't bid properly and we're going to save billions of dollars."
The US government, Trump said, is paying much more for medicines than the open market price would be, therefore, transparent bidding is vital in order to counter the powerful pharma lobbies. Subsequently, the market sentiment shifted toward expectations of lower biotech and drug industry premiums down the road, resulting in a selloff in related stocks.
"Our drug industry has been disastrous, they're leaving left and right," Trump said. "They supply our drugs but they don"t make them here, to a large extent." Obamacare, Trump said, must be repealed and replaced "essentially simultaneously."
The iShares Nasdaq Biotech exchange-traded fund (ETF) plunged 4pc in its biggest one-day decline in three months. S&P Pharmaceuticals, Biotechnology & Life Sciences Index dipped 1.7pc "When the president-elect says we're going to negotiate drug pricing, you have to take that seriously, but at the same this is a complicated issue because there's not going to be clarity on drug pricing reform anytime soon," Brad Loncar of the Loncar Cancer Immunotherapy ETF said. "When somebody that high profile says something that negative, people do not want to invest in it."

Initially, when Trump was still a candidate for the US presidency, he was perceived as pharma industry champion, and his most recent remarks align him with Congress Democrats in a way, who, however, tend to favour tougher administrative regulation rather than proper and transparent competitive bidding. Trump might have become disgruntled with select industries doing business with the US government most recently because of high costs of their services to US taxpayers, and President-elect is committed to cut the expenses of the federal government as part of his fiscal strategy.

During the 20 minutes of Trump's press conference, big pharma lost some $24.6 bln out of its aggregate market value of $906.8 bln.

In particular, equities of Celgene dropped 3.5pc on Wednesday afternoon; Johnson & Johnson retreated 1.61pc; Bristol-Myers dropped 5.5pc; Pfizer declined by 2.75pc; Amgen slid 2.27pc; AbbVie lost 4.2pc; Gilead shed 2.3pc; and Eli Lilly tumbled 2.6pc.

Shares of the Kenilworth, NJ-based Merck & Co., Inc were surprisingly up 1.67pc because of the news of the Food and Drug Administration having decided to speed up their review of Merck's proposed lung-cancer medicine.

Previously, Trump criticised defence enterprises for overcharging the US government, including the highly publicised story focusing on Air Force One, dubbed by Trump as "too expensive." During the press conference on Wednesday, Trump mentioned Lockheed Martin, Ford, and United Technologies amongst the companies whose business practices are harmful to the US economic interests, mainly, in the form of consumer goods being produced overseas and subsequently imported into the US.

The drug industry, on its part, has greatly benefitted from the Obamacare reform, which attracted more funds out of Americans' pockets into the sphere of medical services. The bloated budget spending of the past eight years has also resulted in significant redistribution of wealth towards the well-connected Washington lobbies, with pharma being among the biggest.

Despite his critical stance on the issue of drug prices, and the cautious support from the Democrats, including the now-again-independent Bernie Sanders, Trump is still seen by big pharma as good news. The S&P Biotech Index is still 9pc above its election day level.

"We look forward to working with the new administration and Congress to advance proactive, practical solutions to improve the marketplace and make it more responsive to the needs of patients," Stephen Ubl of Washington-based Pharmaceutical Research and Manufacturers of America (PhRMA) said.
Source: Sputnik News

Receive News from Operation Disclosure via Email

Shoutbox Disclaimer

Please be advised that the Shoutbox is NOT moderated. Use it at your own will.